Search

everythinglearnresearchcommunity

for

Search:↓

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

Blocking S100A8 can reduce chemotherapy-induced hair loss.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Scientists improved an enzyme to better produce a hair growth-promoting chemical from an immunosuppressant.

Aromatase inhibitors can cause skin issues, especially with anastrozole and exemestane, so monitoring is important.

Alstonia boonei phytochemicals show promise as alternative treatments for BPH with fewer side effects than current drugs.

Certain drugs that block specific enzymes can help treat prostate diseases.

Oral zinc sulphate reduces dark hair color in mice.

Compounds from Alpinia zerumbet may help with hair regrowth and cancer treatment by targeting PAK1.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

Cedrol may prevent hair loss caused by chemotherapy better than minoxidil.

Finasteride metabolites found in pigs match human studies, making pigs a valid model for human drug research.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Targeting EGFR may help reduce hair loss from chemotherapy.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Cuscuta reflexa extracts helped regrow hair in rats with drug-induced hair loss.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Pexidartinib often causes liver issues and fatigue, especially in women.

Balancing testosterone may reduce COVID-19 severity.

A woman developed severe kidney injury from using simvastatin with ciclosporin, highlighting the need for careful monitoring when combining these drugs.

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.

The reconstructed skin model from hair follicles functions like human skin in processing chemicals and can be used to test ingredient safety.

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.